04:54:42 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Research Report Identifies Flotek Industries, SuperValu, NextEra Energy, Acadia Healthcare, LHC Group, and Alnylam Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-02-08 07:45 ET - News Release

NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Flotek Industries, Inc. (NYSE:FTK), SuperValu Inc. (NYSE:SVU), NextEra Energy, Inc. (NYSE:NEE), Acadia Healthcare Company, Inc. (NASDAQ:ACHC), LHC Group (NASDAQ:LHCG), and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

FTK DOWNLOAD: http://Fundamental-Markets.com/register/?so=FTK
SVU DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SVU
NEE DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NEE
ACHC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ACHC
LHCG DOWNLOAD:
http://Fundamental-Markets.com/register/?so=LHCG
ALNY DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ALNY

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Flotek Industries, Inc. (NYSE:FTK), SuperValu Inc. (NYSE:SVU), NextEra Energy, Inc. (NYSE:NEE), Acadia Healthcare Company, Inc. (NASDAQ:ACHC), LHC Group (NASDAQ:LHCG), and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 6th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

FLOTEK INDUSTRIES, INC. (FTK) REPORT OVERVIEW

Flotek Industries' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Flotek Industries reported revenue of $79.46MM vs $64.34MM (up 23.50%) and basic earnings per share -$0.05 vs -$0.05. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Flotek Industries reported revenue of $262.83MM vs $269.97MM (down 2.64%) and basic earnings per share -$0.88 vs -$0.25. Flotek Industries is expected to report earnings on February 14th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is $0.31 and is expected to report on February 14th, 2018.

To read the full Flotek Industries, Inc. (FTK) report, download it here: http://Fundamental-Markets.com/register/?so=FTK

-----------------------------------------

SUPERVALU INC. (SVU) REPORT OVERVIEW

SuperValu's Recent Financial Performance

For the three months ended November 30th, 2017 vs November 30th, 2016, SuperValu reported revenue of $3,938.00MM vs $3,003.00MM (up 31.14%) and basic earnings per share $0.67 vs -$0.69. For the twelve months ended February 28th, 2017 vs February 29th, 2016, SuperValu reported revenue of $12,480.00MM vs $12,907.00MM (down 3.31%) and basic earnings per share $17.14 vs $4.76 (up 260.29%). SuperValu is expected to report earnings on April 24th, 2018. The report will be for the fiscal period ending February 28th, 2018. The reported EPS for the same quarter last year was $0.91. The estimated EPS forecast for the next fiscal year is $2.51 and is expected to report on April 24th, 2018.

To read the full SuperValu Inc. (SVU) report, download it here: http://Fundamental-Markets.com/register/?so=SVU

-----------------------------------------

NEXTERA ENERGY, INC. (NEE) REPORT OVERVIEW

NextEra Energy's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, NextEra Energy reported revenue of $4,808.00MM vs $4,805.00MM (up 0.06%) and basic earnings per share $1.80 vs $1.63 (up 10.43%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, NextEra Energy reported revenue of $16,155.00MM vs $17,486.00MM (down 7.61%) and basic earnings per share $6.29 vs $6.11 (up 2.95%). NextEra Energy is expected to report earnings on April 20th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.75. The estimated EPS forecast for the next fiscal year is $8.21 and is expected to report on January 25th, 2019.

To read the full NextEra Energy, Inc. (NEE) report, download it here: http://Fundamental-Markets.com/register/?so=NEE

-----------------------------------------

ACADIA HEALTHCARE COMPANY, INC. (ACHC) REPORT OVERVIEW

Acadia Healthcare's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Acadia Healthcare reported revenue of $716.71MM vs $734.67MM (down 2.44%) and basic earnings per share $0.52 vs -$1.36. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Acadia Healthcare reported revenue of $2,810.91MM vs $1,794.49MM (up 56.64%) and basic earnings per share $0.07 vs $1.65 (down 95.76%). Acadia Healthcare is expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $2.45 and is expected to report on February 22nd, 2018.

To read the full Acadia Healthcare Company, Inc. (ACHC) report, download it here: http://Fundamental-Markets.com/register/?so=ACHC

-----------------------------------------

LHC GROUP (LHCG) REPORT OVERVIEW

LHC Group's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, LHC Group reported revenue of $272.87MM vs $230.80MM (up 18.23%) and basic earnings per share $0.61 vs $0.55 (up 10.91%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, LHC Group reported revenue of $914.82MM vs $816.37MM (up 12.06%) and basic earnings per share $2.08 vs $1.86 (up 11.83%). LHC Group is expected to report earnings on March 14th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.58. The estimated EPS forecast for the next fiscal year is $2.66 and is expected to report on March 14th, 2018.

To read the full LHC Group (LHCG) report, download it here: http://Fundamental-Markets.com/register/?so=LHCG

-----------------------------------------

ALNYLAM PHARMACEUTICALS, INC.  (ALNY) REPORT OVERVIEW

Alnylam Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Alnylam Pharmaceuticals reported revenue of $17.10MM vs $13.65MM (up 25.24%) and basic earnings per share -$1.34 vs -$1.21. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Alnylam Pharmaceuticals reported revenue of $47.16MM vs $41.10MM (up 14.75%) and basic earnings per share -$4.79 vs -$3.45. Alnylam Pharmaceuticals is expected to report earnings on February 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$1.32. The estimated EPS forecast for the next fiscal year is -$5.69 and is expected to report on February 8th, 2018.

To read the full Alnylam Pharmaceuticals, Inc. (ALNY) report, download it here: http://Fundamental-Markets.com/register/?so=ALNY

-----------------------------------------

ABOUT  FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

 

© 2024 Canjex Publishing Ltd. All rights reserved.